This study investigates the effects of acute increases in plasma free fatty acid (FFA) levels on glucose production and utilization in humans. The research was conducted on 26 healthy volunteers under three controlled experimental conditions: euglycemic hyperinsulinemia (Group A), hyperglycemic hyperinsulinemia (Group B), and hyperglycemia with basal insulin levels (Group C). In each group, FFA levels were elevated using lipid-heparin infusions, and the impact on glucose metabolism was assessed. In Group A, elevated FFA levels significantly reduced total glucose uptake and suppressed endogenous glucose production, even when insulin levels were maintained at a high level. In Group B, similar results were observed, with FFA-induced impairment in glucose utilization despite increased FFA concentrations. In Group C, which simulated a diabetic state with hyperglycemia and insulin deficiency, lipid infusion had no effect on glucose uptake but significantly increased endogenous glucose production. The study found that FFA compete with glucose for uptake by peripheral tissues, particularly under conditions of high insulin levels. However, when insulin is deficient, elevated FFA levels may contribute to hyperglycemia by enhancing endogenous glucose output rather than through competition for fuel utilization. The findings suggest that FFA can influence glucose metabolism in different ways depending on the presence or absence of insulin. The study also highlights the importance of insulin in regulating glucose utilization and the potential role of FFA in insulin resistance. Overall, the results indicate that FFA can have significant effects on glucose metabolism, particularly in the context of insulin deficiency.This study investigates the effects of acute increases in plasma free fatty acid (FFA) levels on glucose production and utilization in humans. The research was conducted on 26 healthy volunteers under three controlled experimental conditions: euglycemic hyperinsulinemia (Group A), hyperglycemic hyperinsulinemia (Group B), and hyperglycemia with basal insulin levels (Group C). In each group, FFA levels were elevated using lipid-heparin infusions, and the impact on glucose metabolism was assessed. In Group A, elevated FFA levels significantly reduced total glucose uptake and suppressed endogenous glucose production, even when insulin levels were maintained at a high level. In Group B, similar results were observed, with FFA-induced impairment in glucose utilization despite increased FFA concentrations. In Group C, which simulated a diabetic state with hyperglycemia and insulin deficiency, lipid infusion had no effect on glucose uptake but significantly increased endogenous glucose production. The study found that FFA compete with glucose for uptake by peripheral tissues, particularly under conditions of high insulin levels. However, when insulin is deficient, elevated FFA levels may contribute to hyperglycemia by enhancing endogenous glucose output rather than through competition for fuel utilization. The findings suggest that FFA can influence glucose metabolism in different ways depending on the presence or absence of insulin. The study also highlights the importance of insulin in regulating glucose utilization and the potential role of FFA in insulin resistance. Overall, the results indicate that FFA can have significant effects on glucose metabolism, particularly in the context of insulin deficiency.